US24823R1059 - Common Stock
DENALI THERAPEUTICS INC
NASDAQ:DNLI (4/23/2024, 7:00:01 PM)
After market: 16.11 0 (0%)16.11
+0.12 (+0.75%)
Denali Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates for neurodegenerative diseases. The company is headquartered in South San Francisco, California and currently employs 447 full-time employees. The company went IPO on 2017-12-08. The firm is focused on developing a portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases and lysosomal storage disease. The Company’s clinical-stage programs include Antibody Transport Vehicle (ATV): triggering receptors expressed on myeloid cells 2 (TREM2), Protein Transport Vehicle (PTV): progranulin (PGRN), eukaryotic initiation factor 2 B (eIF2B), receptor-interacting serine/threonine protein kinase 1 (RIPK1), Enzyme Transport Vehicle (ETV): iduronate 2-sulfatase (IDS) and leucine-rich repeat kinase 2 (LRRK2), which are in various Phases ranging from Phase I through Phase III. The Company’s product candidates include DNL310, TAK-594/DNL593, TAK-920/DNL919, BIIB122/DNL151, DNL343, SAR443820/DNL788 and SAR443122/DNL758. The firm engineers its product candidates to cross the BBB, and act directly in the brain.
DENALI THERAPEUTICS INC
161 Oyster Point Blvd
South San Francisco CALIFORNIA 94080
P: 16508668548
CEO: Ryan J. Watts
Employees: 447
Website: https://www.denalitherapeutics.com
/PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, has been named to Fast Company's prestigious list of the World's Most Innovative...
With the Fear and Greed Index at 69, it's an opportune to wager on these attractive Stocks with Moonshot Potential.
Denali Therapeutics (DNLI) stock rises amid plans to raise $500M through a private placement. Read more here.
Here you can normally see the latest stock twits on DNLI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: